Debated in Parliament on 9 May 2022.
Mr Chua Kheng Wee Louis asked the Minister for Health what is the Government's position on the use of the traditional Chinese medicine (TCM) Lianhua Qingwen Jiao Nang capsules in Singapore.
Lianhua Qingwen Jiaonang (LHQW) 莲花清瘟胶囊 capsules are classified as Chinese Proprietary Medicines (CPMs) in Singapore, approved for the relief of cold and flu symptoms. CPMs are not intended for the prevention, treatment or cure of specific diseases.
We are aware of claims circulating on social media platforms that LHQW can be used to prevent or treat COVID-19. To date, there is no conclusive evidence from controlled clinical studies to substantiate those claims. Locally, there is an ongoing local study to investigate the effectiveness of LHQW in reducing COVID-19 symptoms.
PAPERCUTS